Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

News & Analysis

China biotech company and industry news and analysis...

Week in Review: CStone Pharma, a Suzhou Oncology Company, Files for Hong Kong IPO
I-Mab Acquires China Rights to I-O mAb from MorphoSys in $105 Million Deal
NextCure Closes $93 Million B Round Led by China Investors for IO Therapies
Agilent Closes $250 Million Acquisition of ACEA, a US-China Lab Tools Maker
CStone Pharma Files for Hong Kong IPO to Support its Oncology Portfolio
Upcoming event
ChinaBio Partnering Forum 2019
Shanghai , China
May 8-9, 2019
 
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

ChinaBio® Events